Toggle Main Menu Toggle Search

Open Access padlockePrints

Transient but not genetic loss of miR-451 is protective in the development of pulmonary arterial hypertension

Lookup NU author(s): Dr Jenny Grant

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

MicroRNAs are small noncoding RNAs involved in the regulation of gene expression and haverecently been implicated in the development of pulmonary arterial hypertension (PAH). Previous work hasestablished that miR-451 is upregulated in rodent models of PAH. The role of miR-451 in the pulmonarycirculation is unknown. We therefore sought to assess the involvement of miR-451 in the development ofPAH. Silencing of miR-451 was performed in vivo using miR-451 knockout mice and an anti-miR targetingmature miR-451 in rats. Coupled with exposure to hypoxia, indices of PAH were assessed. The effect ofmodulating miR-451 on human pulmonary artery smooth muscle cell proliferation and migration was analyzed.We observed a reduction in systolic right ventricular pressure in hypoxic rats pretreated with anti-miR-451 compared with hypoxia alone (47:7  1:36 mmHg and 56:0  2:03 mmHg, respectively; P < :01). InmiR-451 knockout mice, compared with wild-type hypoxic mice, no significant differences were observedfollowing exposure to chronic hypoxia. In vitro analysis demonstrated that overexpression of miR-451 inhuman pulmonary artery smooth muscle cells promoted migration under serum-free conditions. No effect oncellular proliferation was observed. In conclusion, transient inhibition of miR-451 attenuated the developmentof PAH in hypoxia-exposed rats. Genetic deletion of miR-451 had no beneficial effect on indices of PAH,potentially because of pathway redundancy compensating for the loss of miR-451.


Publication metadata

Author(s): Grant JS, Morecroft I, Dempsie Y, vanRooij E, MacLean MR, Baker AH

Publication type: Article

Publication status: Published

Journal: Pulmonary Circulation

Year: 2013

Volume: 3

Issue: 4

Pages: 840-850

Print publication date: 01/12/2013

Online publication date: 03/02/2014

Acceptance date: 28/09/2013

ISSN (print): 2045-8932

ISSN (electronic): 2045-8940

Publisher: Pulmonary Vascular Research Institute

URL: http://www.jstor.org/stable/10.1086/674751


Share